eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


3/2018
vol. 17
 
Share:
Share:
abstract:
Review paper

Premature ovarian insufficiency – hormone replacement therapy and management of long-term consequences

Paulina Machura
,
Monika Grymowicz
,
Ewa Rudnicka
,
Wojciech Pięta
,
Anna Calik-Ksepka
,
Jolanta Skórska
,
Roman Smolarczyk

Menopause Rev 2018; 17(3): 135-138
Online publish date: 2018/09/30
View full text Get citation
 
PlumX metrics:
Premature ovarian insufficiency (POI) correlates with increased risk of cardiovascular diseases, osteoporosis, genitourinary syndrome, and other symptoms of prolonged oestrogen deprivation. Properly selected therapy improves the quality of women’s lives and reduces the risk of mortality. There is a wide spectrum of available oestrogen and progestogen formulations restoring proper levels of serum sex steroid hormones. The treatment should be implemented at recognition of the POI and continued to at least the age of natural menopause. Transdermal oestradiol and oral or vaginal progesterone administration provide the most physiological sex steroid replacement therapy. Patients’ views and individual preference according the route, dose, and regimen of hormonal treatment have to be taken into consideration in order to achieve high compliance rates. Women with POI should be managed by a multidisciplinary team, such as a gynaecologist, endocrinologist, dietitian, and psychologist.
keywords:

hormone replacement therapy, premature ovarian insufficiency

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.